Clinical trial
Rituximab Treatment for Psychosis And/or Obsessive Compulsive Disorder with Probable Immune System Involvement
NCT04323566
Study timeline
Study start (actual)2022-05-01Date precision: day
Registry last updated2024-11-19
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Obsessive-Compulsive Disorderunresolved
Obsessive-Compulsive Behaviorunresolved
Schizophreniaunresolved
Delusional Disorderunresolved
Brief Psychotic Disorderunresolved
Schizo Affective Disorderunresolved
Other Psychosesunresolved
Unspecified Psychosisunresolved
Interventions
RituximabDRUG · verified · RxNorm: rituximab
Sponsors & collaborators
Uppsala University Hospitallead sponsor
Uppsala Universitycollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04323566 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.